Oneness Biotech Co., Ltd. (4743.TWO)
TWD 57.1
(-9.37%)
TWD 57.1
(-9.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 32.56 Million TWD | -96.14% |
| 2022 | 844.39 Million TWD | 1774.6% |
| 2021 | 45.04 Million TWD | 46.64% |
| 2020 | 30.71 Million TWD | 970.91% |
| 2019 | -3.52 Million TWD | -140.78% |
| 2018 | 8.64 Million TWD | 533.55% |
| 2017 | 1.36 Million TWD | -52.14% |
| 2016 | 2.85 Million TWD | -4.46% |
| 2015 | 2.98 Million TWD | 3.0% |
| 2014 | 2.89 Million TWD | 57.41% |
| 2013 | 1.84 Million TWD | -34.23% |
| 2012 | 2.79 Million TWD | 298.15% |
| 2011 | 703 Thousand TWD | -97.83% |
| 2010 | 32.34 Million TWD | 2604.1% |
| 2009 | 1.19 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -95.7 Million TWD | 4.37% |
| 2024 Q2 | -94.62 Million TWD | 1.13% |
| 2023 Q1 | 10.62 Million TWD | 187.74% |
| 2023 Q2 | 6.39 Million TWD | -39.83% |
| 2023 FY | -381.69 Million TWD | -145.2% |
| 2023 Q3 | 6.75 Million TWD | 5.57% |
| 2023 Q4 | -100.07 Million TWD | -1582.14% |
| 2022 Q3 | 4.93 Million TWD | -99.41% |
| 2022 Q1 | 6.74 Million TWD | -47.77% |
| 2022 FY | 844.39 Million TWD | 1774.6% |
| 2022 Q4 | 3.69 Million TWD | -25.1% |
| 2022 Q2 | 829.02 Million TWD | 12189.09% |
| 2021 Q2 | 9.85 Million TWD | 48.79% |
| 2021 Q3 | 15.65 Million TWD | 58.86% |
| 2021 FY | 45.04 Million TWD | 46.64% |
| 2021 Q4 | 12.91 Million TWD | -17.47% |
| 2021 Q1 | 6.62 Million TWD | 445.47% |
| 2020 Q2 | 28.4 Million TWD | 6944.82% |
| 2020 FY | 30.71 Million TWD | 970.91% |
| 2020 Q4 | 1.21 Million TWD | -19.71% |
| 2020 Q1 | -415 Thousand TWD | -160.67% |
| 2020 Q3 | 1.51 Million TWD | -94.68% |
| 2019 Q2 | -1.96 Million TWD | -923.44% |
| 2019 Q1 | -192 Thousand TWD | -105.41% |
| 2019 Q4 | 684 Thousand TWD | 133.3% |
| 2019 FY | -3.52 Million TWD | -140.78% |
| 2019 Q3 | -2.05 Million TWD | -4.53% |
| 2018 Q4 | 3.55 Million TWD | 225.27% |
| 2018 Q1 | 1.16 Million TWD | 119.25% |
| 2018 Q2 | 2.84 Million TWD | 144.58% |
| 2018 Q3 | 1.09 Million TWD | -61.58% |
| 2018 FY | 8.64 Million TWD | 533.55% |
| 2017 Q2 | 338 Thousand TWD | 24.72% |
| 2017 FY | 1.36 Million TWD | -52.14% |
| 2017 Q4 | 530 Thousand TWD | 134.51% |
| 2017 Q3 | 226 Thousand TWD | -33.14% |
| 2017 Q1 | 271 Thousand TWD | -55.93% |
| 2016 Q4 | 615 Thousand TWD | -33.51% |
| 2016 Q3 | 925 Thousand TWD | 49.68% |
| 2016 Q2 | 618 Thousand TWD | -10.95% |
| 2016 Q1 | 694 Thousand TWD | 1926.32% |
| 2016 FY | 2.85 Million TWD | -4.46% |
| 2015 Q3 | 715 Thousand TWD | -64.99% |
| 2015 Q2 | 2.04 Million TWD | 667.67% |
| 2015 Q1 | 266 Thousand TWD | -65.94% |
| 2015 FY | 2.98 Million TWD | 3.0% |
| 2015 Q4 | -38 Thousand TWD | -105.31% |
| 2014 Q4 | 781 Thousand TWD | -33.48% |
| 2014 FY | 2.89 Million TWD | 57.41% |
| 2014 Q3 | 1.17 Million TWD | 92.78% |
| 2014 Q2 | 609 Thousand TWD | 82.34% |
| 2014 Q1 | 334 Thousand TWD | 127.21% |
| 2013 Q3 | 296 Thousand TWD | -69.55% |
| 2013 Q4 | 147 Thousand TWD | -50.34% |
| 2013 FY | 1.84 Million TWD | -34.23% |
| 2013 Q2 | 972 Thousand TWD | 128.17% |
| 2013 Q1 | 426 Thousand TWD | -71.18% |
| 2012 Q3 | 821 Thousand TWD | 64.86% |
| 2012 Q4 | 1.47 Million TWD | 80.02% |
| 2012 Q1 | 2000.00 TWD | -99.71% |
| 2012 FY | 2.79 Million TWD | 298.15% |
| 2012 Q2 | 498 Thousand TWD | 24800.0% |
| 2011 FY | 703 Thousand TWD | -97.83% |
| 2011 Q1 | 2000.00 TWD | -99.99% |
| 2011 Q2 | - TWD | -100.0% |
| 2011 Q3 | - TWD | 0.0% |
| 2011 Q4 | 701 Thousand TWD | 0.0% |
| 2010 Q2 | 3.47 Million TWD | 7000.0% |
| 2010 FY | 32.34 Million TWD | 2604.1% |
| 2010 Q4 | 22.07 Million TWD | 227.3% |
| 2010 Q1 | 49 Thousand TWD | 0.0% |
| 2010 Q3 | 6.74 Million TWD | 93.82% |
| 2009 FY | 1.19 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 91.911% |
| Level Biotechnology Inc. | 219.54 Million TWD | 85.168% |
| Sagittarius Life Science Corp | 71.47 Million TWD | 54.444% |
| NeoCore Technology Co., Ltd. | -9.08 Million TWD | 458.415% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 85.543% |
| GlycoNex Incorporation | 995 Thousand TWD | -3172.563% |
| VBI | 16.42 Million TWD | -98.271% |
| GeneReach Biotechnology Corp. | 27.58 Million TWD | -18.047% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 83.592% |
| Visgeneer Inc. | 67.48 Million TWD | 51.747% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 108.679% |
| Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 97.682% |
| G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 77.479% |
| Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 85.856% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -43.18% |
| Enimmune corporation | -23.37 Million TWD | 239.315% |
| TaiRx, Inc. | 2.43 Million TWD | -1235.055% |
| CHO Pharma, Inc. | -28.27 Million TWD | 215.146% |
| EirGenix Inc. | 236.74 Million TWD | 86.246% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 68.796% |
| Sunny Pharmtech Inc. | 285.52 Million TWD | 88.596% |
| Lin BioScience, Inc. | -17.92 Million TWD | 281.637% |
| BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 63.666% |
| Feng Chi Biotech Corp. | 80.72 Million TWD | 59.661% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -2906.648% |
| Lukas Biomedical Inc. | 133.89 Million TWD | 75.68% |
| RBC Bioscience Corporation | 72.89 Million TWD | 55.33% |
| BiOptic Inc. | 152.74 Million TWD | 78.682% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -36080.0% |
| Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | -388.406% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -1145.201% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 94.943% |
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -9797.264% |
| SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -6149.904% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 72.845% |
| Neith Corporation | 18.01 Million TWD | -80.709% |
| Advagene Biopharma Co., Ltd. | -12 Million TWD | 371.305% |
| NaviFUS Corp. | 11.82 Million TWD | -175.319% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 66.353% |
| Sinew Pharma Inc. | -28.98 Million TWD | 212.341% |
| Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -10303.195% |
| Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 91.703% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 21.501% |
| AP Biosciences Inc | 32.25 Million TWD | -0.958% |
| Medigen Biotechnology Corp. | 617.32 Million TWD | 94.725% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -517.406% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 89.646% |
| Intech Biopharm Corporation | -163.99 Million TWD | 119.855% |
| Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 908.191% |
| TWi Biotechnology, Inc. | -9.73 Million TWD | 434.346% |
| Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 93.283% |
| TCI GENE Inc. | 174.61 Million TWD | 81.352% |
| MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 296.145% |
| Senhwa Biosciences, Inc. | -10.17 Million TWD | 420.083% |
| Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 57.357% |
| NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 57.691% |
| PharmaEngine, Inc. | 718.97 Million TWD | 95.471% |
| Savior Lifetec Corporation | 220.94 Million TWD | 85.263% |
| TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 70.845% |
| OBI Pharma, Inc. | -73.49 Million TWD | 144.304% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 76.552% |
| Acepodia, Inc. | 16.59 Million TWD | -96.239% |
| Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | -18.541% |